Results 71 to 80 of about 10,828 (178)

Hiding in plain sight: DICER1‐associated yolk sac tumour masquerading as an endometrioid carcinoma of the ovary

open access: yes
Histopathology, Volume 89, Issue 2, Page 390-392, August 2026.
Lili Fu   +4 more
wiley   +1 more source

Clinical significance of lncRNA PAX8-AS1 and miR-96-5p in non-small cell lung cancer

open access: yesJournal of Cardiothoracic Surgery
Background This study aims to examine the potential value of lncRNA PAX8-AS1 and miR-96-5p as diagnostic markers in non-small cell lung cancer (NSCLC).
Qiaoling Ying   +5 more
doaj   +1 more source

Bisphenol A interferes with TTF-1 and PAX8 modulation of dual oxidase 2 human thyroid promoter activity

open access: yesAcademia Molecular Biology and Genomics
Bisphenol A (BPA) is an endocrine disruptor related to the increasing prevalence of goiter and thyroid malignancy. PAX8 and TTF-1 control the expression of the main thyroid differentiation markers, including dual oxidase (Duox) 2, that are ...
Luciana DomĂȘnico Queiroz   +6 more
doaj   +1 more source

Role of PAX8 in the tumorigenesis of ovarian cancer [PDF]

open access: yes, 2015
PAX8 is a member of the Paired box (PAX) multigene family of transcription factors, which are involved in the tissue-specific control of the expression of several genes during development of both vertebrates and invertebrates. Previously, PAX8 has been studied as key molecular marker and regulator of follicular thyrocyte differentiation, but recent ...
openaire   +1 more source

Ascitic Fluid in Ovarian Mass with Special Reference to Paired-box Gene 8 Immunoexpression: A Cross-sectional Analysis

open access: yesInternational Journal of Advanced Medical and Health Research
Introduction: Mortality in the case of ovarian malignancy is high due to late diagnosis. Early and accurate diagnosis can improve case-specific management.
Prabhat Mahato   +4 more
doaj   +1 more source

High expression of PAX8-AS1 correlates with poor prognosis and response to fluorouracil-based chemotherapy in stage II colon cancer

open access: yesTranslational Oncology
Decisions regarding adjuvant therapy in patients with stage II colon cancer remains controversial and challenging. We aimed to determine novel biomarkers that help to predict relapse free survival (RFS) and identify a subset of patients with stage II ...
Hongsheng Fang   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy